Showing results (571-580 of 2,903) with videos related to
Sort By:
Pageof 291
Cancer Gene Therapy|March 5, 2022
Pigment epithelium-derived factor, an anti-VEGF factor, delays ovarian cancer progression by alleviating polarization of tumor-associated macrophagesRui Ma, Xiaolin Chu, Yiting Jiang, et al.Cancer Gene Therapy|March 3, 2022
Review of bi-specific therapies in uveal melanomaMarlana Orloff, Rino Seedor, Takami SatoCancer Gene Therapy|April 8, 2022
Protein post-translational modifications in the regulation of cancer hallmarksHaiying Wang, Liqian Yang, Minghui Liu, et al.Cancer Gene Therapy|April 4, 2022
Alternative splicing events in tumor immune infiltration in renal clear cell carcinomasZhiqiang Wang, Liping Zhu, Kesang Li, et al.Cancer Gene Therapy|March 26, 2022
SUMOylation inhibition enhances multiple myeloma sensitivity to lenalidomideLi Du, Wei Liu, Flavia Pichiorri, et al.Cancer Gene Therapy|March 26, 2022
LncRNA SNHG5 promotes the proliferation and cancer stem cell-like properties of HCC by regulating UPF1 and Wnt-signaling pathwayYarui Li, Junbi Hu, Dan Guo, et al.Cancer Gene Therapy|September 22, 2021
The LIN28B/TGF-β/TGFBI feedback loop promotes cell migration and tumour initiation potential in cholangiocarcinomaNattapong Puthdee, Sira Sriswasdi, Trairak Pisitkun, et al.Cancer Gene Therapy|October 18, 2019
Specific glioblastoma multiforme prognostic-subtype distinctions based on DNA methylation patternsHuihui Ma, Chenggang Zhao, Zhiyang Zhao, et al.Cancer Gene Therapy|May 10, 2019
Down-regulation of 14-3-3zeta reduces proliferation and increases apoptosis in human glioblastomaXiaoliang Yang, Weidong Cao, Xiaofeng Wang, et al.Cancer Gene Therapy|May 10, 2019
Preferential sensitivity to HDAC inhibitors in tumors with CREBBP mutationMalte Hellwig, Daniel J Merk, Beat Lutz, et al.Pageof 291